GlaxoSmithKline is buying Novartis’ stake in the firms’ consumer healthcare unit, the announcement coming just days after the drug giant said it would not pursue acquisition of Pfizer’s consumer healthcare business.
With its important multiple sclerosis business facing off against growing competition, Biogen plans to get further involved in an "attractive value creation" prospect: a biosimilars ......